TOP 10 Tumor treatment in North Haven, Connecticut

PAMELA LYN KUNZ is a renowned institution located at 6 Devine Street in North Haven, Connecticut, United States. Dr. Kunz is an international leader in the treatment and clinical research of patients with GI malignancies and neuroendocrine tumors (NETs). She holds several prestigious leadership positions in the field, including President Emeritus of the North American Neuroendocrine Tumor Society and recent past Chair of the Neuroendocrine Tumor Taskforce of the National Cancer Institute. Dr. Kunz is also a member of the FDA’s Oncology Drug Advisory Committee and currently serves as the Editor-in-Chief for JCO Oncology Advances. In addition to her focus on NETs, she is a leading advocate for diversity, equity, and inclusion in medicine. Dr. Kunz served as the Vice Chief of DEI for the Section of Medical Oncology at Yale School of Medicine and was awarded 'Woman Oncologist of the Year' in 2021 by Women Leaders in Oncology for her work in promoting gender equity. Visit PAMELA LYN KUNZ to learn more about Dr. Kunz and her groundbreaking work in the field of oncology.

Jeremy Kortmansky, MD is a specialized medical institution located at 6 Devine Street in North Haven, Connecticut, United States. Dr. Kortmansky focuses on the treatment of gastrointestinal neuroendocrine tumors, which are cancers that develop in the digestive tract. These tumors can form in various parts of the gastrointestinal system, such as the small intestine, stomach, rectum, appendix, and more. The institution also provides care for gastrointestinal cancers, which occur when DNA changes lead to the growth of malignant cells along the gastrointestinal tract. Patients can learn about the symptoms and treatment options available for these types of cancers.

Dr. Natalia Neparidze is a renowned doctor specializing in multiple myeloma, monoclonal gammopathies, AL amyloidosis, and Waldenstrom's macroglobulinemia. Located at 6 Devine Street in North Haven, Connecticut, Dr. Neparidze obtained her medical degree from Aieti Medical School in Tbilisi, Georgia in 2000. She has since completed various fellowships and residencies at prestigious institutions such as Emory, Northwestern, and Yale Universities. Dr. Neparidze has been serving as an assistant professor at Yale University School of Medicine, Medical Oncology/Hematology since 2012. She leads the Yale Myeloma Research team and is actively involved in developing research projects and clinical trials in the field of myeloma. Her research interests include advanced imaging, precision medicine approaches, immunotherapy strategies, and tumor progression mechanisms in myeloma. In addition to her research, Dr. Neparidze is dedicated to educating and mentoring Hematology/Oncology fellows, medical students, residents, and colleagues at Yale and in the community.